 - Progressive hormone-refractory disease after orchiectomy or gonadotropin-releasing hormone analog andor anti-androgen treatment within 12 months of screening based on 1 of the following: Transaxial imaging tumor progression, Rise in 2 consecutive prostate-specifec antigen PSA values obtained at least 7 days apart or Radionucleotide bone scan progression 